Insider Trading History of Leavitt Chase C.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Leavitt Chase C. since 2019. This trader's CIK number is 1777467. At the time of last reporting, Leavitt Chase C. was the General Counsel/Secretary of Oncternal Therapeutics, Inc.. (stock ticker symbol ONCT). Also see all insider trading activities at Oncternal Therapeutics, Inc..

Note that in the past Leavitt Chase C. also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Oncternal Therapeutics, Inc. (ONCT) by Leavitt Chase C.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 ONCT 25,000 $7,250 0 $0 0 $0
2022 ONCT 13,500 $23,279 0 $0 0 $0

Yearly summary of insider trading at Lineage Cell Therapeutics, Inc. (LCTX) by Leavitt Chase C.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2019 LCTX 5,000 $5,100 0 $0 0 $0


Insider trading activities at 2 companies by Leavitt Chase C.:

1. Oncternal Therapeutics, Inc. (ONCT)

2. Lineage Cell Therapeutics, Inc. (LCTX)

Table 1. Insider trading of Oncternal Therapeutics, Inc. (ONCT) by Leavitt Chase C.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-04-13 ONCT Buy 10,000 .29 2,900
2023-04-12 ONCT Buy 15,000 .29 4,350
2022-01-28 ONCT Buy 5,000 1.63 8,149
2022-01-27 ONCT Buy 8,500 1.78 15,130

Table 2. Insider trading of Lineage Cell Therapeutics, Inc. (LCTX) by Leavitt Chase C.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2019-08-13 LCTX Buy 5,000 1.02 5,100

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Leavitt Chase C. (General Counsel/Secretary of Oncternal Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.